Skip to main content
All lobbying clients

AMGEN

Lobbying client · California · filed 2025 to 2026

Biotechnology.

$360,000 Reported spend
6 Filings counted
1 Firms hired
9 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (213700), not by name.

 Firms hired 1
 Bills named in these filings 9
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
    5 filings
  • HR 1990
    American Innovation and R&D Competitiveness Act of 2025
    2 filings
  • HR 946
    ORPHAN Cures Act
    2 filings
  • S 1862
    ORPHAN Cures Act
    2 filings
  • S 3788
    CLEAR LABELS Act
    2 filings
  • HR 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
    1 filing
  • S 1954
    Biosimilar Red Tape Elimination Act
    1 filing
  • S 2658
    Medication Affordability and Patent Integrity Act
    1 filing
  • S 3014
    Ensuring Timely Access to Generics Act of 2025
    1 filing
 Reported by year 2 years
  • 2026 $120,000 2 filings
  • 2025 $240,000 4 filings
 Issues lobbied 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 6
  • HOUSE OF REPRESENTATIVES 6
  • SENATE 6
  • Centers For Medicare and Medicaid Services (CMS) 5
  • Executive Office of the President (EOP) 5
  • Health & Human Services, Dept of (HHS) 5
  • Office of Management & Budget (OMB) 5

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem